Item 9 Labs Corporation (EM) (INLB)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Form 8-K - Current report

Current Report Filing (8-k)

0001500123 false 0001500123 2023-06-27 2023-06-27 iso4217:USD xbrli:shares...

Quarterly Report (10-q)

0001500123 false true Q2 2023 --09-30 true

Current Report Filing (8-k)

0001500123 false 0001500123 2023-05-22 2023-05-22 iso4217:USD xbrli:shares...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION   Washing, D.C. 20549 SEC FILE NUMBER   000-54730 FORM...

Current Report Filing (8-k)

0001500123 false 0001500123 2023-05-12 2023-05-12 iso4217:USD xbrli:shares...

Current Report Filing (8-k)

0001500123 false 0001500123 2023-05-04 2023-05-04 iso4217:USD xbrli:shares...

Current Report Filing (8-k)

0001500123 false 0001500123 2023-03-10 2023-03-10 iso4217:USD xbrli:shares...

Quarterly Report (10-q)

0001500123 false true Q1 2023 --09-30 true

Annual Report (10-k)

0001500123 false true FY 2022 --09-30 DE AZ true

Analysts Have Conflicting Sentiments on These Healthcare Companies: Item 9 Labs (OtherINLB) and Baudax Bio (BXRX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Item 9 Labs (INLB – Research Report) and Baudax Bio (BXRX –...